Viability Imaging in Volumetric Angiography (VIVA 1)

Stopped early · Not applicable

Conditions studied: Myocardial Scarring

In brief

The primary objective of this study is twofold: 1. To define inter-reader variability of myocardial viability imaging within the first pass and delayed enhancement cardiac CT perfusion imaging 2. To evaluate DE CT image quality using a consensus DECT protocol

Key facts

Study ID

NCT01408134

Run by

Medstar Health Research Institute

People needed

10

Starts

2011-06-01

Expected to finish

2013-02-01

Last updated by the study team

2013-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Eligible patients will be adults, ages 18 and above with:
• Known CAD with prior MI based upon clinical history or electrocardiographic criteria
• Planned redo-surgical myocardial revascularization
• Referred for CT (and eligible) for pre-op substernal mapping/coronary artery evaluation

You may not qualify if…

• Inability to provide informed consent
• Allergy to iodinated contrast media (unless pre-medicated with medical prophylaxis)
• Chronic kidney disease manifested by a serum creatinine >1.5 mg/dL, an estimated creatinine clearance <50 ml/kg/min or on dialysis
• Currently reporting or evaluated in NYHA class IV heart failure

Where it is running

• Washington Hospital Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.